-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) Misses Q2 EPS by 46c ; Offers Guidance
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Raised to $1,370 at Truist Securities
-
-
-
-
-
-
-
Goldman Sachs on Eli Lilly (LLY): 'see the stock weakness as an overreaction'
-
-
-
-
-
-
-
Lilly to acquire Ajax Therapeutics for up to $2.3 billion
-
-
-
-
-
-
-
BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
-
-
-
-
-
-
-
UBS Reiterates Buy Rating on Eli Lilly (LLY), Bullish on Orfo
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) Tops Q4 EPS by 34c, Beats on Revenue; Offers FY26 Guidance
-
1,223,213 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

